We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GWAV:NASDAQGreenwave Technology Solutions, Inc. Analysis

Data as of 2026-04-07 - not real-time

$3.56

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Greenwave Technology Solutions is trading well below its short‑term moving averages, with the price sitting beneath both the 20‑day and 50‑day SMA, indicating a bearish technical backdrop. The RSI hovers around the mid‑40s, suggesting limited upside momentum, while the MACD has just turned bullish, offering a faint technical glimmer. Volume is on the rise, but the stock faces extreme 30‑day volatility and a beta that exceeds the market, amplifying price swings. Fundamentally, the company shows strong top‑line growth but suffers from deep operating losses, negative cash flows, and a debt load that dwarfs its cash reserves, raising solvency concerns. The price‑to‑book ratio is strikingly low, and the PE is near zero, reflecting a market discount that may be more about risk than value. Overall, the blend of weak profitability, high leverage, and volatile price action points to a high‑risk, speculative play.
Investors should weigh the potential upside from the low valuation against the substantial financial distress and sector‑specific regulatory pressures. The lack of dividend payments confirms that income‑focused investors have little to gain. Given the current technical and fundamental landscape, any position should be approached with caution, reserving capital for more stable opportunities unless a clear turnaround catalyst emerges.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 3/10

Key Factors

  • price below all key moving averages
  • persistent operating losses and high debt
  • elevated volatility and beta

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • strong revenue growth despite margin pressure
  • price near a technical support level
  • potential upside if cash flow improves

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • extremely low price‑to‑book suggesting deep discount
  • ongoing financial distress could limit upside
  • industry exposure to environmental regulation

Key Metrics & Analysis

Financial Health

Revenue Growth49.00%
Profit Margin-84.21%
P/E Ratio0.0
ROE-79.20%
ROA-18.33%
Debt/Equity43.02
P/B Ratio0.1
Op. Cash Flow$-8358988
Free Cash Flow$-8379901
Industry P/E29.7

Technical Analysis

TrendBearish
RSI45.0
Support$3.24
Resistance$4.00
MA 20$3.68
MA 50$4.00
MA 200$9.59
MACDBullish
VolumeIncreasing
Fear & Greed Index77.61

Valuation

GradeUndervalued
TypeBlend

Risk Assessment

Beta1.11
Volatility57.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.